ApoGen Biotechnologies, Inc. vs PDC Therapeutics

ApoGen Biotechnologies, Inc. logo

ApoGen Biotechnologies, Inc.

1 employees · est. 2014 · Seattle, United States

VS
PDC Therapeutics logo

PDC Therapeutics

Biotechnology start-up developing targeted Polymer-Drug Conjugate platform technologies, named Sagitta®

4 employees · est. 2020 · Lausanne, Switzerland

ApoGen Biotechnologies, Inc. is the older company (2014 vs 2020); PDC Therapeutics is the larger of the two.

Side-by-Side Comparison

ApoGen Biotechnologies, Inc. PDC Therapeutics
Founded
2014 older 2020
Headquarters
Seattle, United States Lausanne, Switzerland
Employees
1 4 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology
Funding Stage
Series A Not tracked yet
Total Funding
$11.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Taxonomy
OncologyPharmaceuticalsTherapeuticsCancer Drug ResistanceGenomic MutationImmunotherapy +8 Polymer-Drug ConjugateSagitta®TherapeuticsNanomedicinesCancer TherapyBiodegradable Conjugation +8
Website
apogenbiotech.com pdcbio.com
ApoGen Biotechnologies, Inc. logo

About ApoGen Biotechnologies, Inc.

ApoGen Biotechnologies, Inc. is a biotechnology startup founded in 2014 and headquartered in the United States. The company focuses on addressing a persistent challenge in cancer treatment - drug resistance. Despite the evolution of cancer therapies, drug resistance remains a significant hurdle, lea...

PDC Therapeutics logo

About PDC Therapeutics

PDC Therapeutics is a biotechnology start-up founded in 2020 and headquartered in Switzerland. The company focuses on developing targeted Polymer-Drug Conjugate technologies under the proprietary Sagitta® platform, aiming to provide patients with an optimal therapeutic index. PDC Therapeutics collab...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches ApoGen Biotechnologies, Inc. and PDC Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when ApoGen Biotechnologies, Inc. or PDC Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

ApoGen Biotechnologies, Inc. was founded in 2014, based in Seattle, United States, with 1 employees. ApoGen Biotechnologies, Inc. is a biotechnology startup founded in 2014 and headquartered in the United States. The company focuses on addressing a persistent challenge in cancer treatment - drug resi. PDC Therapeutics was founded in 2020, based in Lausanne, Switzerland, with 4 employees. PDC Therapeutics is a biotechnology start-up founded in 2020 and headquartered in Switzerland. The company focuses on developing targeted Polymer-Drug Conjugate technologies under the proprietary Sagi.
ApoGen Biotechnologies, Inc. has raised $11.00M and PDC Therapeutics no disclosed funding. Latest stage: ApoGen Biotechnologies, Inc. Series A.
Both work in Biotechnology and list therapeutics and drug development among their focus areas.

Compare ApoGen Biotechnologies, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ApoGen Biotechnologies, Inc. on 12 Sep 2024, and PDC Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes